scholarly journals Plant-based food supplement developing and studying its role in optimizing carbohydrate and fat metabolism of people with diabetes under conditions of agriculture digitization

2020 ◽  
Vol 176 ◽  
pp. 03020
Author(s):  
M.I. Kalimullin ◽  
S.S. Sadi ◽  
B. Tokhiriyon ◽  
V.M. Poznyakovsky ◽  
S.S. Andrievskikh
Keyword(s):  
Type 2 Diabetes ◽  
Functional Properties ◽  
Raw Materials ◽  
Fat Metabolism ◽  
Film Coating ◽  
Food Supplement ◽  
Biologically Active ◽  
Agriculture And Food ◽  
Tablet Hardness

Under conditions of digital economy, in particular, agriculture and food industry, specialized food products, including biologically active food supplements produced from natural raw materials, are increasingly used to improve nutrition and health, and to maintain quality of life. These products are affordable and efficient in coping with metabolism disorders caused by different diseases. Taking all these factors into account the authors developed a pant-based food supplement aimed at improving metabolism of people with type 2 diabetes. The composition of this specialized product is scientifically based in terms of its ingredients and their active substances biochemical and synergetic properties. The innovative production technology of this biologically active food supplement involves pressing its main ingredients and auxiliary substances into tablets. The tablet form provides accurate dosage, convenient packaging and storage, reliable film coating, which ensures tablet hardness and protection from aggressive exposure. The food supplement properties have been determined, including its nutritional value and functional properties. One tablet includes: ascorbic acid – 8.6 mg, chromium -0.1mg, zinc – 2.3 mg, flavonoids – 10mg, tannins – 20 mg, manganese – 0.8mg. Clinical trials proved the supplement efficacy and functional properties. People with type 2 diabetes took 1 tablet of phyto-complex twice a day alongside sugar-lowering drugs. After one month they demonstrated lower levels of blood glucose, total cholesterol and triglycerides as well as better overall health and lower body mass index. The obtained data clearly indicate better pancreas functions, improved microcirculation, carbohydrate and fat metabolism normalizing. The article also provides recommendations of the supplement intake for people with type 2 diabetes and glucose tolerance disorders.

312-OR: Gender-Specific Effects on Hepatic Fat Metabolism in Type 2 Diabetes before and after Remission

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 312-OR
Author(s):  
AHMAD AL-MRABEH ◽  
SHADEN MELHEM ◽  
SVIATLANA V. ZHYZHNEUSKAYA ◽  
CARL PETERS ◽  
ALISON C. BARNES ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Fat Metabolism ◽  
Specific Effects ◽  
Before And After ◽  
Hepatic Fat ◽  
Gender Specific

scholarly journals Polysaccharide from Okra (Abelmoschus esculentus (L.) Moench) Improves Antioxidant Capacity via PI3K/AKT Pathways and Nrf2 Translocation in a Type 2 Diabetes Model

Molecules ◽  
2019 ◽  
Vol 24 (10) ◽  
pp. 1906 ◽  
Author(s):  
Zhengzheng Liao ◽  
Jingying Zhang ◽  
Bing Liu ◽  
Tingxu Yan ◽  
Fanxing Xu ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Body Weight ◽  
Glycogen Synthase ◽  
Density Lipoprotein ◽  
Biologically Active ◽  
Lipoprotein Cholesterol ◽  
Abelmoschus Esculentus ◽  
Heme Oxygenase 1 ◽  
Hepatic Glycogen

Polysaccharide extracted from okra (Abelmoschus esculentus (L.) Moench), a traditional functional food, is a biologically active substance reported to possess hypoglycemic and anti-oxidative qualities. However, it is unknown which polysaccharides play a role and have the potential mechanism. This present study is to assess the possible impacts of a novel polysaccharide isolated from okra (OP) on mice fed with a high-fat diet (HFD) combined with an intraperitoneal injection (i.p.) of 100 mg/kg streptozotocin (STZ) twice, to induce type 2 diabetes mellitus (T2DM). We found that an eight-week administration of OP at 200 or 400 mg/kg body weight significantly alleviated the symptoms, with elevations in blood glucose, triglyceride (TG), total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C), as well as reducing high-density lipoprotein cholesterol (HDL-C), body weight, food, and water consumption. The OP treatment increased the hepatic glycogen and decreased the mussy hepatic cords and liver fibrosis in the T2DM mice. The decreases of ROS and MDA and the increases of SOD, GSH-Px and CAT in liver were observed after administration of OP. OP alleviated the T2DM characteristics through the activation of the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/glycogen synthase kinase 3 beta (GSK3β) pathway, and enhanced the nuclear factor erythroid-2 (Nrf2) expression and promoted Nrf2-medicated heme oxygenase-1(HO-1) and superoxide dismutase 2 (SOD2) expression. OP also relieved mitochondrial dysfunction by inhibiting NOX2 activation. Taken together, these findings suggest that a polysaccharide isolated from okra exerts anti-T2DM effects partly by modulating oxidative stress through PI3K/AKT/GSK3β pathway-medicated Nrf2 transport. We have determined that a polysaccharide possesses hypoglycemic activity, as well as its underlying mechanism.

Imatinib Mesylate Induced Reversal of Leukemic Gene Phenotype in HL60 Cells Coincides with Stimulation of Oxidative Metabolism.

Blood ◽  
2007 ◽  
Vol 110 (11) ◽  
pp. 4190-4190
Author(s):  
Michael Pfeilstocker ◽  
Peter Wihlidal ◽  
Franz Varga ◽  
Elisabeth Pittermann ◽  
Heidrun Karlic
Keyword(s):  
Type 2 Diabetes ◽  
Transcription Factors ◽  
Cell Line ◽  
Imatinib Mesylate ◽  
Oxidative Metabolism ◽  
Myeloid Leukemia ◽  
Fat Metabolism ◽  
Fold Stimulation ◽  
Stimulation Of

Abstract Besides blockade of tyrosine kinases such as c-kit, Imatinib mesylate (IM) regulates glucose flux through downregulation of GLUT-1 transporters in human leukemia cells. This mechanism has the potential to induce regression of type 2 diabetes and hyperlipidemia as observed in patients with chronic myeloid leukemia or hypereosinophilic syndrome. In addition, there is a stimulatory effect of IM on differentiation of human mesenchymal stem cells. Its synergism with retinoic acid or low dose Ara-C is applied in treatment of acute myeloid leukemia (AML). Thus, the AML-derived c-kit positive cell line HL60 was chosen for studying the effect of IM on expression of genes associated with differentiation and metabolism. We analysed the possible feedback on transcription factors (AML1 and AML3) and consequences regarding differentiation and metabolism - associated genes. Quantitative reverse transcriptase PCR analyses revealed that IM treatment of HL60 cells downregulates mRNA synthesis of AML1 and AML3 by 70% without affecting transcription of the c-abl tyrosine kinase. IM reduces expression of CD34 mRNA from 20% to 6% of the housekeeping gene G6PD. The appearance of differentiated cells was accompanied by a remarkable stimulation of mRNAs from CD11b and CD14 (monocyte markers) reaching 4-fold higher expression levels relative to G6PD. This was associated with an increased proportion of osteocalcin (OCN), which has recently been shown to enhance mitochondrial activity. A 2-fold stimulation of a fat-metabolism associated mitochondrial palmitoyltransferase (CPT1B) and 10-fold stimulation of microsomal carnitine palmitoyltransferase and the carnitine transporter OCTN2 supports previous data indicating an IM-associated stimulation of oxidative metabolism resulting in a regression of type-2 diabetes and hyperlipidemia. Our current investigations show that IM-associated attenuation of cell proliferation inhibited transcription factors AML1 and AML3 and triggered differentiation in the leukemic cell line HL60, as reflected by altered mRNA expression of surface marker genes. The IM - induced stimulation of lipid metabolism in HL60 confirms previous data indicating a reversal of the Warburg effect in K562 cells without cytocidal activity. This indicates a similar mechanism as known for other drugs and strategies targeting glucose or fat metabolism, which are discussed in the context of cancer prevention and treatment.

scholarly journals The interaction between polyphenols and food proteins: prospects for diet therapy of metabolic syndrome and type 2 diabetes mellitus

2018 ◽  
Vol 64 (4) ◽  
pp. 252-257
Author(s):  
Vladimir K. Mazo ◽  
Nikita A. Petrov ◽  
Varuzhan A. Sarkisyan ◽  
Alla A. Kochetkova
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Metabolic Syndrome ◽  
Type 2 Diabetes Mellitus ◽  
Biologically Active ◽  
Food Proteins ◽  
Food Ingredients ◽  
The Metabolic Syndrome ◽  
Lipid Metabolism Disorders

The use of minor biologically active components of food (flavonoids) as functional food ingredients for foods for special dietary uses is a promising trend in prevention and treatment of carbohydrate and lipid metabolism disorders resulting from the metabolic syndrome and type 2 diabetes mellitus. Unlike the in vitro studies that are conducted mainly on cell cultures, the results of clinical studies may be influenced by low bioavailability of polyphenols. This fact makes it impossible to reach the beneficial effects of polyphenols in some cases. Thus, the problem of polyphenol bioavailability enhancement is the main direction in producing highly effective specialized anti-diabetic food products. In this review, the interaction between proteins and polyphenolic compounds is discussed from the viewpoint of the potential to protect polyphenols against degradation in the digestive tract, to increase their stability and pharmacological activity compared to those of the conventional compositions. The problems of interactions between polyphenols and food proteins, digestive enzymes and cell transporters in the gastrointestinal tract have not been sufficiently covered in Russian academic publications. The studies focused on the mechanisms of interactions between polyphenols and proteins, considering the corresponding structural changes are of interest for predicting possible changes in their bioavailability. Polyphenol binding to proteins is influenced by the primary structure of a protein macromolecule, the spatial distribution of amino acid residues responsible for polyphenol binding, and some other parameters characterizing the conditions of interactions.

scholarly journals PREDICTORS AND PREMORBID CONDITIONS OF THE DEVELOPMENT OF FEMALE GENITAL CANCER, IN PARTICULAR ENDOMETRY CANCER AND BREAST CANCER

2021 ◽  
Vol 3 (17) ◽  
pp. 75-83
Author(s):  
A. Petruk ◽  
O. Lytvak ◽  
A. Khabrat
Keyword(s):  
Breast Cancer ◽  
Type 2 Diabetes ◽  
Amino Acids ◽  
Tissue Growth ◽  
Biologically Active ◽  
Genital Cancer ◽  
Increased Risk ◽  
Risk Of Cancer ◽  
Female Genital

Objective: to review a new potential diagnostic criteria for predictors and premorbid conditions of female genital cancer, including endometrial cancer and breast cancer. Materials and methods. Bibliographic, information-analytical methods were used in the work. Sources of information were data from the scientific literature on the topic of the study, modern gadleins, a review of randomized controlled trials. Results. The results of epidemiological studies suggest that the increased risk of cancer of the female reproductive system is the presence of obesity and type 2 diabetes. Potential mechanisms of their association are hyperinsulinemia, hyperglycemia, chronic inflammation, and insulin resistance. Because insulin is a major regulator of cell metabolism and is a tissue growth factor, hyperinsulinemia increases the risk of cancer. Hyperinsulinemia is associated with increased secretion of androgens by the ovaries and decreased levels of the protein that binds sex hormones, leading to higher concentrations of biologically active estrogens, which are also known to be risk factors for female genital cancer. In recent years, PFAA profiles have been found to be significantly altered in cancer and type 2 diabetes. Because cancer cells require certain amino acids to synthesize DNA, tumor growth factors, build new blood vessels, and duplicate all of their protein content, changes in PFAA profiles can be used as biomarkers of disease and different types of cancer at different stages. Conclusions. With the growing incidence of cancer, the issue of early diagnosis and detection of cancer in the pre-clinical stages remains relevant. Protein metabolism in cancer remains unclear and requires further research using a larger sample size. In addition, the biological mechanisms by which amino acids may contribute to the risk and progression of cancer or other premorbid conditions need to be elucidated. Determining the exact mechanism underlying changes in PFAA profiles has great potential for cancer diagnosis and treatment.

TECHNOLOGY OF PRODUCTION OF BIOLOGICALLY ACTIVE PLANT COMPLEX: DETERMINATION OF REGULATED PARAMETERS, FUNCTIONAL PROPERTIES

2019 ◽  
Keyword(s):  
Functional Properties ◽  
Viral Infections ◽  
Raw Materials ◽  
Extraction Process ◽  
Biologically Active ◽  
Raw Material ◽  
Quantitative Composition ◽  
Comprehensive Treatment ◽  
Plant Raw Materials ◽  
Technology Of Production

The technology of production of a biologically active phytocomplex in the form of a biologically active additive has been discussed. The qualitative and quantitative composition of the formulation, which forms the functional properties of a specialized product, has scientifically been determined. The main stages of production include the preparation and input control of the raw material, the preparation of a mixture for encapsulation, including the steps of dispensing, sieving, grinding and mixing at a rate of 100 kg / 1 h, encapsulation and deducting, packaging, packaging and storage. A description of the technology of ex-traction of plant raw materials has been given, which is of great importance in the formation of consumer properties of the product being developed. The extraction process includes: obtaining liquid recovery us-ing demineralized water with dissolved in it sodium bicarbonate in an amount of 8% of the dry feed con-tent. The extractant-raw ratio is 1:13, the extraction time is 4 hours for each time; thickening of the liquid extract. It is carried out by means of vacuum in a vacuum evaporator plant before obtaining an extract with a solids content of not less than 20%; obtaining a dry extract. It is carried out by spray drying at a temperature of 90-95 ° C. The advantage of the developed technology of dietary supplements is the possi-bility of combining several differently directed biologically active substances in one capsule. The gelati-nous membrane reliably protects the contents from various environmental factors. Functional properties of the formulation formula of a specialized product are aimed at the prevention and comprehensive treatment of infectious viral diseases, confirmed by the conclusion of experts from the Russian Federal Service for Consumer Rights and Consumer Protection and the results of clinical trials in a group of pa-tients with acute respiratory viral infections. The developed product has been approved and produced at the enterprises of the company «Art Life».

Sign in / Sign up

Export Citation Format

Share Document